Liquidia Becomes 30th Manufacturer to Limit Access to 340B Pricing in Contract Pharmacy Setting

Liquidia recently became the 30th drug manufacturer to restrict access to 340B pricing in the contract pharmacy setting.
Drugmaker Liquidia will implement contract pharmacy restrictions for a single drug that has a still-pending new drug application (NDA). The [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Virginia Legislature Passes 340B Contract Pharmacy Bill, Sends to Governor’s Desk

Virginia General Assembly building and grounds
The Virginia House of Delegates and Senate both overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions in the state.
The Virginia house today overwhelmingly cleared a bill to bar drugmaker 340B contract pharmacy restrictions, two weeks after the state [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B Contract Pharmacy Bills Die in Oregon, Utah; Oklahoma Bills Clear Committees in Both Chambers

Oregon state lawmakers pulled a bill to bar drugmaker 340B contract pharmacy restrictions shortly after a similar Utah bill died in committee.
Two bills introduced in Oregon and Utah to bar drugmaker 340B contract pharmacy restrictions are now effectively dead, and provider [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

100 Days and Counting: ADR Final Rule Still Under White House Review

Stephen Kuperberg, principal at the Law Offices of Stephen Kuperberg, said the Supreme Court underscored the importance of having a well-functioning ADR process.
After missing its self-imposed deadline of publishing the 340B administrative dispute resolution final rule by the end of 2023, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Visante Webinar: 340B Current Issues and Policy Update

SPONSORED CONTENT

Join us for in an informative and timely 340B webinar scheduled for March 13th at 11:30 AM CT! Ted Slafsky, CEO of 340B Report, and Kristin Fox-Smith from Visante will share insights on 340B policy and litigation updates, along with valuable strategies to

Read More »

Idaho Becomes Nineteenth State to Introduce a 340B Contract Pharmacy Bill

Idaho is the nineteenth state to introduce legislation to bar drugmaker 340B contract pharmacy restrictions this session.
Idaho state lawmakers this week introduced a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Takeda Adds Drug to 340B Contract Pharmacy Restrictions

Takeda 340B
Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.
After implementing its first contract pharmacy restrictions in January, Japanese pharmaceutical giant Takeda recently subjected another drug to conditions on [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Lacks Authority to Reverse 340B Child Site Registration Policy, Hospital Group Tells Court

U.S. District Court of the District of Columbia
A hospital association asked the U.S. District Court of the District of Columbia to side with more than 40 health systems that sued federal regulators over a hospital registration policy change.
A 340B hospital association this week asked a federal court to bar, without a full trial, federal regulators from reversing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Expert Tip from Sectyr, LLC

img
img

TIP: Make transparency and visibility the cornerstones of your 340B program.


As manufacturers continue to impose

Read More »

Amgen Extends Contract Pharmacy Restrictions to Grantees, Receives Early Pushback

Amgen wordmark on building facade
Drugmaker Amgen last week extended its existing 340B contract pharmacy restrictions to federal grantees.
Biopharmaceutical manufacturer Amgen recently expanded its conditions on 340B pricing at contract pharmacies to include grantees. The Thousand Oaks, California-based [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live